中国心脏起搏与心电生理杂志

参考文献

1　中国生物医学工程学会心脏起搏与心电生理分会,中华医学会心血管病学分会,中华心血管病杂志编辑委员会,等.胺碘酮抗心律失常治疗应用指南[J].中国心脏起搏与心电生理杂志,2004,18(6):401

2　Kodama I,Kamiya K,Toyama J.Cellular electropharmacology of amiodarone[J].Cardiovascular Research,1997,35:13

3　周琳,蒋彬,蒋文平,等.胺碘酮对大鼠肥厚心肌细胞急性电生理作用的研究[J].中华心血管病杂志,2006,34:164

4　Goldschlager N,Epstein AE,Naccarelli G,et al.Practice Guidelines Subcommittee,North American Society of Pacing and Electrophysiol-ogy.Practical guidelines for clinicians who treat patients with amiod-arone[J].Arch Intern Med,2000,160:1741

5　Vorperian VR,Havighurst TC,Miller S,et al.Adverse effects of lowdose amiodarone:a meta-analysis[J].J AmColl Cardiol,1997,30:791

6　Miller JM,Zipes DP.Therapy for cardiac arrhythmias.In:Zipes DP,Libby PBRO,Braunwald E.eds.Braunwald′s heart disease:a textbook of cardiovascular medicine[M].7th ed.Philadelphia:WBSaunders,2005.730-731

7　中华医学会心血管病分会.中国部分地区心房颤动住院病例回顾性调查[J].中华心血管病杂志,2003,31:913

8　周自强,胡大一,陈捷,等.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43:491

9　Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC2006Guidelines for the Management of Patients With Atrial Fibrillation:a report of the American College of Cardiology/American Heart Asso-ciation Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Revise the2001Guidelines for the Management of Patients With Atrial Fibrillation):developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[J].Circu-lation,2006,114:e257

10　Letelier LM,Udol K,Ena J,et al.Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm:a meta-analysis[J].Arch Intern Med,2003,163:777

11　Khan IA,Mehta NJ,Gowda RM.Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation[J].Int J Cardiol,2003,89:239

12　Bianconi L,Castro A,Dinelli M,et al.Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter:a multicentre,randomized,double blind,placebo-controlled study[J].Eur Heart J,2000,21:1265

13　AFFIRM Clinical Trial Center,Axio Research Corporation.First Antiarrhythmic Drug Substudy Investigators.Maintenance of sinus rhythm in patients with atrial fibrillation:an AFFIRM substudy of the first antiarrhythmic drug[J].J Am Coll Cardiol,2003,42:20

14　Kochiadakis GE,Igoumenidis NE,Simantirakis EN,et al.Intrave-nous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset:a placebo-controlled study[J].PACE,1998,21:2475

15　Kochiadakis GE,Igoumenidis NE,Marketou ME,et al.Low dose amiodarone and sotalol in the treatment of recurrent,symptomatic at-rial fibrillation:a comparative,placebo controlled study[J].Heart,2000,84:251

16　Martnez-Marcos FJ,Garca-Garmendia JL,Ortega-Carpio A,et al.Comparison of intravenous flecainide,propafenone,and amiodarone for conversion of acute atrial fibrillation to sinus rhythm[J].Am J Cardiol,2000,86:950

17　Joseph AP,Ward MR.A prospective,randomized controlled trial comparing the efficacy and safety of sotalol,amiodarone,and digox-in for the reversion of new-onset atrial fibrillation[J].Ann Emerg Med,2000,36:1

18　Blanc JJ,Voinov C,Maarek M.Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibril-lation[J].Am J Cardiol,1999,84:1029

19　Singh BN,Singh SN,Reda DJ,et al.Amiodarone versus sotalol for atrial fibrillation[J].N Engl J Med,2005,352:1861

20　Roy D,Talajic M,Dorian P,et al.Amiodarone to prevent recur-rence of atrial fibrillation[J].N Engl J Med,2000,342:913

21　Lafuente-Lafuente C,Mouly S,Longas-Tejero MA,et al.Antiarrhyth-mic drugs for maintaining sinus rhythmafter cardioversion of atrial fi-brillation:a systematic review of randomized controlled trials[J].Arch Intern Med,2006,166:719

22　刘坤申,边树怀,夏岳,等.胺碘酮在心房颤动复律和预防复发中的作用[J].中国心脏起搏与心电生理杂志,2001,15:308

23　牛凡,黄从新,江洪,等.胺碘酮和索他洛尔治疗心房颤动的随机对比研究[J].中华医学杂志,2006,86:121

24　Wyse DG,Waldo AL,DiMarco JP,et al.Acomparison of rate con-trol and rhythm control in patients with atrial fibrillation[J].NEngl J Med,2002,347:1825

25　Delle Karth G,Geppert A,Neunteufl T,et al.Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachya-rrhythmias[J].Crit Care Med,2001,29:1149

26　Boriani G,Biffi M,Frabetti L,et al.Ventricular fibrillation after in-travenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation[J].Am Heart J,1996,131:1214

27　Schützenberger W,Leisch F,Gmeiner R.Enhanced accessory path-way conduction following intravenous amiodarone in atrial fibrilla-tion:a case report[J].Int J Cardiol,1987,16:93

28　Perticone F,Cuda G,Spadea F,et al.Malignant ventricular ar-rhythmia in the Wolff-Parkinson-White syndrome during amiodarone treatment[J].Clin Cardiol,1987,10:477

29　Blomstr m-Lundqvist C,Scheinman MM,Aliot EM,et al.ACC/AHA/ESC Guidelines for the Management of Patients With Su-praventricular Arrhythmias-executive summary:a report of the A-merican College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Ar-rhythmias)[J].Circulation,2003,108:1871

30　Singh SN,Fletcher RD,Fisher SG,et al.Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmi-a:Survival Trial of Antiarrhythmic Therapy in Congestive Heart Fail-ure[J].N Engl J Med,1995,333:77

31　Deedwania PC,Singh BN,Ellenbogen K,et al.Spontaneous con-version and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation:observations from the Veter-ans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy(CHF-STAT)[J].Circulation,1998,98:2574

32　Neuberger HR,Mewis C,van Veldhuisen DJ,et al.Management of atrial fibrillation in patients with heart failure[J].Eur Heart J,2007,28:2568

33　Fuster V,Rydén LE,Cannom DS,et al.ACC/AHA/ESC2006guidelines for the management of patients with atrial fibrillation-exec-utive summary:a report of the American College of Cardiology/A-merican Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Revise the2001Guidelines for the Manage-ment of Patients with Atrial Fibrillation)[J].Eur Heart J,2006,27:1979

34　Hernandez-Madrid A,Bueno MG,Rebollo JG,et al.Use of irbesar-tan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation:a prospective and randomize study[J].Circula-tion,2002,106:331

35　Chun SH,Sager PT,Stevenson WG,et al.Long-termefficacy of amio-darone for the maintenance of normal sinus rhythm in patients with re-fractory atrial fibrillation or flutter[J].Am J Cardiol,1995,76:47

36　Gosselink AT,Crijns HJ,Van Gelder IC,et al.Low-dose amioda-rone for maintenance of sinus rhythm after cardioversion of atrial fi-brillation or flutter[J].JAMA,1992,267:3289

37　Natale A,Newby KH,Pisano E,et al.Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter[J].J Am Coll Cardiol,2000,35:1898

38　Da Costa A,Thévenin J,Roche F,et al.Results from the Loire-Ard埁che-Dr?me-Is埁re-Puy-de-D?me(LADIP)trial on atrial flut-ter,a multicentric prospective randomized study comparing amioda-rone and radiofrequency ablation after the first episode of symptomat-ic atrial flutter[J].Circulation,2006,114:1676

39　Miller MR,McNamara RL,Segal JB,et al.Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent mainte-nance of sinus rhythm:a meta-analysis of clinical trials[J].J Fam Pract,2000,49:1033

40　Cybulski J,Kulakowski P,Makowska E,et al.Intravenous amioda-rone is safe and seems to be effective in termination of paroxysmal supraventricular tachyarrhythmias[J].Clin Cardiol,1996,19:563

41　Villain E,Vetter VL,Garcia JM,et al.Evolving concepts in the management of congenital junctional ectopic tachycardia:a multi-center study[J].Circulation,1990,81:1544

42　陶萍,陶寿淇,许美龄,等.静脉注射乙胺碘呋酮对心律失常的疗效观察[J].中华内科杂志,1984,1:1

43　Paul T,Bertram H,Bokenkamp R,et al.Supraventricular tachycar-dia in infants,children and adolescents:diagnosis,and pharmaco-logical and interventional therapy[J].Paediatr Drugs,2000,2:171

44　ECC Committee,Subcommittee and task forces of the American Heart Association.2005American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care[J].Circulation,2005,112:Ⅳ1

45　杨艳敏,朱俊,宋有城,等.静脉胺碘酮在危及生命的室性心律失常中的应用[J].中国心脏起搏与心电生理杂志,2001,15:298

46　Kudenchuk PJ,Cobb LA,Copass MK,et al.Amiodarone for resus-citation after out-of-hospital cardiac arrest due to ventricular fibrilla-tion[J].N Engl J Med,1999,341:871

47　Dorian P,Cass D,Schwartz B,et al.Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation[J].N Engl J Med,2002,346:884

48　Credner SC,Klingenheben T,Mauss O,et al.Electrical storm in patients with transvenous implantable cardioverter-defibrillators:in-cidence,management and prognostic implications[J].J Am Coll Cardiol,1998,32:1909

49　Helmy I,Herre JM,Gee G,et al.Use of intravenous amiodarone for emergency treatment of life threatening ventricular arrhythmias[J].J Am Coll Cardiol,1988,12:1015

50　Nademanee K,Taylor R,Bailey WE,et al.Treating electrical storm:sympathetic blockade versus advanced cardiac life support-guided therapy[J].Circulation,2000,102:742

51　Amiodarone Trials Meta-Analysis Investigators.Effect of prophylac-tic amiodarone on mortality after acute myocardial infarction and in congestive heart failure:meta-analysis of individual data from6500patients in randomised trial[J].Lancet,1997,350:1417

52　Cairns JA,Connolly SJ,Roberts R,et al.Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations CAMIAT[J].Lancet,1997,349:675

53　Julian DG,Camm AJ,Frangin G,et al.European Myocardial Infarct Amiodarone Trial Investigators.Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent my-ocardial infarction:EMIAT[J].Lancet,1997,349:667

54　Freemantle N,Cleland J,Young P,et al.Beta blockade after myo-cardial infarction:systematic review and meta regression analysis[J].BMJ,1999,318:1730

55　Nuttall SL,Toescu V,Kendall MJ.Beta blockade after myocardial infarction:beta blockers have key role in reducing morbidity and mortality after infarction[J].BMJ,2000,320:581

56　Moss AJ,Hall WJ,Cannom DS,et al.Multicenter Automatic De-fibrillator Implantation Trial Investigators.Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia[J].N Engl J Med,1996,335:1933

57　Buxton AE,Lee KL,Fisher JD,et al.Multicenter Unsustained Tachycardia Trial Investigators:a randomized study of the prevention of sudden death in patients with coronary artery disease[J].N Engl J Med,1999,341:1882

58　Moss AJ,Zareba W,Hall WJ,et al.Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejec-tion fraction[J].N Engl J Med,2002,346:877

59　Bardy GH,Lee KL,Mark DB,et al.Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure[J].N Engl J Med,2005,352:225

60　Bansch D,Antz M,Boczor S,et al.Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy:the cardiomyop-athy trial(CAT)[J].Circulation,2002,105:1453

61　Strickberger SA,Hummel JD,Bartlett TG,et al.Amiodarone ver-sus implantable cardioverter defibrillator randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsus-tained ventricular tachycardia-AMIOVIRT[J].J Am Coll Cardiol,2003,41:1707

62　CASCADE Investigators.Randomized antiarrhythmic drug therapy in survivors of cardiac arrest(the CASCADE Study)[J].Am J Cardi-ol,1993,72:280

63　Connolly SJ,Dorian P,Roberts RS,et al.Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients(OPTIC)Investigators.Comparison of betablockers amiodarone plus beta-blockers,or sotalol for prevention of shocks from implantable cardioverter defibrillators:the OPTIC Study:a randomized trial[J].JAMA,2006,295:165

64　Antman EM,Anbe DT,Armstrong PW,et al.ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarc-tion-Executive Summary A Report of the American College of Car-diology/American Heart Association Task Force on Practice Guide-lines(Writing Committee to Revise the1999Guidelines for the Management of Patients With Acute Myocardial Infarction)[J].Cir-culation,2004,110:588

65　Aasbo JD,Lawrence AT,Krishnan K,et al.Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery:a meta-analysis[J].Ann Intern Med,2005,143:327

66　赵枫,李莉,徐志云,等.围术期应用胺碘酮预防治疗心脏术后心房颤动[J].中国心脏起搏与心电生理杂志,2006,20:210

67　Mitchell LB,Exner DV,Wyse DG,et al.Prophylactic Oral Amiod-arone for the Prevention of Arrhythmias that Begin Early After Revas-cularization,Valve Replacement,or Repair:PAPABEAR:a ran-domized controlled trial[J].JAMA,2005,294:3093

68　Goldschlager N,Epstein AE,Naccarelli G,et al.Practical guide-lines for clinicians who treat patients with amiodarone[J].Arch In-tern Med,2000,160:1741

69　Harjai KJ,Licata AA.Amiodarone induced hyperthyroidism a case series and brief review of literature[J].PACE,1996,19:1548

70　Harjai KJ,Licata AA.Effects of amiodarone on thyroid function[J].Ann Intern Med,1997,126:63

71　Ott MC,Khoor A,Leventhal JP,et al.Pulmonary toxicity in pa-tients receiving low-dose amiodarone[J].Chest,2003,123:646

72　Kaushik S,Hussain A,Clarke P,et al.Acute pulmonary toxicity after low-dose amiodarone therapy[J].Ann Thorac Surg,2001,72:1760

73　Oikawa H,Maesawa C,Sato R,et al.Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone:a case report[J].World J Gastroenterol,2005,11:5394

74　Roden DM.Antiarrhythmic drugs.In:Goodman LS,Gilman A.eds.Goodman and Gilman′s the pharmacological basis of therapeutics[M].11th ed.New York:McGraw-Hill,2005.920-921

75　Pollak PT.Clinical organ toxicity of antiarrhythmic compounds:ocu-lar and pulmonary manifestations[J].Am J Cardiol,1999,84:37R

76　Raeder EA,Podrid PJ,Lown B.Side effects and complications of amiodarone therapy[J].Am Heart J,1985,109:975

77　Baloch Z,Carayon P,Conte-Devolx B,et al.Laboratory medicine practice guidlines,laboratory support for the diagnosis and monito-ring of thyroid disease[J].Thyroid,2003,13:3